Tigecycline In-Vitro Surveillance Study In Taiwan

Inclusion Criteria: * Clinically relevant causative isolate (no duplicates) - The isolate must meet the laboratory criteria of "significant pathogen" and be considered the "probable causative agent" of a hospital or community acquired infection. * Sources - All body sites are acceptable clinical sources for isolates to be included in this study (Intra-abdominal infection, tracheal secretion/bronchoalveolar lavage, blood culture, wound smear). However, no more than 10 % of all isolates can come from urine cultures. * Within study group - Only isolates defined by the protocol are to be included. Exclusion Criteria: * Limited isolates from sources - No more than 10 % of all isolates from this study will be derived from urine cultures. * No banked or stored isolates. * No duplicate isolates - Only one isolate per patient is permitted. * Outside study group - Any isolate other than those defined by protocol.